| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 620.030.436 $ | +129.300.870 $ | +31,0 % | 10 | 525.260.648 $ | +88.734.087 $ | +34,7 % | 9 | 360.742.586 $ | +200.146.344 $ | +234,6 % | 6 | ||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 163.364.295 $ | +63.773.448 $ | +64,0 % | 1 | 99.590.847 $ | +4.495.001 $ | +4,7 % | 1 | 95.095.846 $ | +51.470.590 $ | +118,0 % | 1 |
| Abivax S.A. | ABVX | → 0 | Schwach | 75.383.950 $ | -26.566.430 $ | -26,1 % | 1 | 101.950.380 $ | -10.542.120 $ | -9,4 % | 1 | 112.492.500 $ | +102.799.950 $ | +1.060,6 % | 1 |
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 90.451.500 $ | +6.979.500 $ | +8,4 % | 1 | 83.472.000 $ | +42.199.766 $ | +102,2 % | 1 | 41.272.234 $ | +21.433.894 $ | +108,0 % | 1 |
| ALUMIS INC. | ALMS | → 0 | Neutral | 62.360.321 $ | +37.660.689 $ | +152,5 % | 1 | ||||||||
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Schwach | 39.603.802 $ | -9.125.709 $ | -18,7 % | 1 | 48.729.511 $ | +19.078.786 $ | +64,3 % | 1 | ||||
| Definium Therapeutics, Inc. | DFTX | → 0 | Schwach | 46.116.000 $ | +16.256.300 $ | +54,4 % | 1 | ||||||||
| ArriVent BioPharma, Inc. | AVBP | → 0 | Schwach | 45.472.216 $ | +5.814.610 $ | +14,7 % | 1 | 39.657.606 $ | +3.291.660 $ | +9,1 % | 1 | 36.365.946 $ | -5.999.650 $ | -14,2 % | 1 |
| Gossamer Bio, Inc. | GOSS | → 0 | Schwach | 43.137.650 $ | -1.703.850 $ | -3,8 % | 1 | 44.841.500 $ | +22.271.000 $ | +98,7 % | 1 | ||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Schwach | 35.398.250 $ | -6.230.100 $ | -15,0 % | 1 | 41.628.350 $ | +21.252.350 $ | +104,3 % | 1 | ||||
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 35.243.800 $ | +9.486.550 $ | +36,8 % | 1 | ||||||||
| OCULAR THERAPEUTIX, INC | OCUL | → 0 | Schwach | 31.850.504 $ | +1.175.944 $ | +3,8 % | 1 | 30.674.560 $ | +8.170.560 $ | +36,3 % | 1 | ||||
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 31.307.582 $ | +31.307.582 $ | 1 | |||||||||
| BioAge Labs, Inc. | BIOA | → 0 | Neutral | 30.572.520 $ | +9.430.980 $ | +44,6 % | 1 | ||||||||
| 620.030.436 $ | +129.300.870 $ | +31,0 % | 10 | 525.260.648 $ | +88.734.087 $ | +34,7 % | 9 | 360.742.586 $ | +200.146.344 $ | +234,6 % | 6 | ||||